SCHEMBL6935602

SCHEMBL6935602

CCCCNC(=O)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1395514 0.93 EPHX1 (0.71)
SCHEMBL7749273 0.91 EPHX1 (0.75)
SCHEMBL14643386 0.91 EPHX1 (0.75)
SCHEMBL9811711 0.91 EPHX1 (0.75)
SCHEMBL18641844 0.91 EPHX1 (0.75)
SCHEMBL7749192 0.91 EPHX1 (0.75)
SCHEMBL6278791 0.85
SCHEMBL19593402 0.85 EPHX1 (0.50)
SCHEMBL320112 0.85 EPHX1 (0.85)
SCHEMBL3139577 0.82 EPHX1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3565808-A1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS Ardelyx, Inc. (US) 2019-11-13 EP claimed
WO-2018129552-A1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS ARDELYX, INC. (US) 2018-07-12 WO claimed
EP-3390382-B1 SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS ARDELYX INC (US) 2021-12-01 EP disclosed
EP-3565808-A1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS Ardelyx, Inc. (US) 2019-11-13 EP disclosed
WO-2018129552-A1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS ARDELYX, INC. (US) 2018-07-12 WO disclosed
CN-102046601-B Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R TECH UENO LTD 2014-08-27 CN disclosed
CN-102083825-B FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof LEGOCHEM BIOSCIENCE LTD 2014-07-30 CN disclosed
CN-101448822-B Substituted pyrazolopyrimidines CEPHALON INC 2013-11-06 CN disclosed
EP-0802195-B1 Substituted 2,3-benzodiazepine derivatives, process and intermediates for their preparation and pharmaceutical compositions comprising them as well as their use EGYT GYOGYSZERVEGYESZETI GYAR (HU) 2003-11-19 EP disclosed
CN-1067685-C Pyridazinoquinoline compounds ZENECA LTD (GB) 2001-06-27 CN disclosed
US-5807851-A MUSCLE RELAXANTS; NERVOUS SYSTEM DISORDERS EGIS GYOGYSZERGYAR RT. (HU) 1998-09-15 US disclosed
EP-0802195-A2 Substituted 2,3-benzodiazepine derivatives, process and intermediates for their preparation and pharmaceutical compositions comprising them as well as their use EGIS GYOGYSZERGYAR RT. (HU) 1997-10-22 EP disclosed
US-4546102-A CARDIOTONIC AGENTS BOEHRINGER INGELHEIM KG (DE) 1985-10-08 US disclosed
EP-0108981-A1 Semicarbazides, their preparation and use BOEHRINGER INGELHEIM KG (DE) 1984-05-23 EP disclosed
US-4069377-A Polymerization of ethylenically unsaturated monomers employing secondary-aliphatic α-substituted azoalkanes PENNWALT CORPORATION 1978-01-17 US disclosed
US-4028344-A FOAMING AGENTS, FREE RADICAL INITIATORS PENNWALT CORPORATION (US) 1977-06-07 US disclosed
US-4025502-A POLYMERIZATION CATALYSTS, CURING AGENTS PENNWALT CORPORATION (US) 1977-05-24 US disclosed